Atlas Trials

A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults

Clinical trial NCT02611492 · UNKNOWN

Trial details

NCT number
NCT02611492
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Philadelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia
Start date
2016-04-01
Primary completion
2020-12-01
Enrollment
265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.